Nureca · NSE: NURECA · BSE: 543264
Q3 FY25 results · Oct–Dec 2024
Nureca reported revenue from operations of ₹26.46 crore (up 18.3% from Q3 FY24) and net loss of ₹2.80 crore for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 26.46 | 22.37 | +18.3% | 31.19 | −15.2% |
| Other income | 1.48 | 5.90 | −75.0% | 3.17 | −53.4% |
| Total income | 27.94 | 28.27 | −1.2% | 34.36 | −18.7% |
| Profit before tax | (3.25) | 0.94 | Turned loss | (0.07) | Loss widened |
| Net profit for the period | (2.80) | 0.17 | Turned loss | (0.48) | Loss widened |
| EPS, basic (₹) | (2.80) | 0.16 | Turned loss | (0.48) | Loss widened |
| Net margin (%) | -10.6 | 0.7 | -1.5 |
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 27.21 | 22.37 | +21.6% | 32.37 | −15.9% |
| Other income | 1.52 | 5.92 | −74.4% | 3.21 | −52.7% |
| Total income | 28.73 | 28.30 | +1.5% | 35.58 | −19.3% |
| Profit before tax | (3.85) | 0.83 | Turned loss | (0.27) | Loss widened |
| Net profit for the period | (3.29) | 0.08 | Turned loss | (0.65) | Loss widened |
| EPS, basic (₹) | (3.29) | 0.08 | Turned loss | (0.65) | Loss widened |
| Net margin (%) | -12.1 | 0.3 | -2.0 |
Consolidated
- Filed with BSE
- 24 Jan 2025, 19:40 IST
- Board meeting
- 24 Jan 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 24 Jan 2025, 19:40 IST
- Board meeting
- 24 Jan 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Audited
- Source
- XBRL filing on BSE